カリフォルニア州におけるCOPDの臨床試験
カリフォルニア州内の拠点で、COPDに関する26件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles9件の研究
- Newport Beach8件の研究
- San Francisco5件の研究
- San Diego4件の研究
- Santa Clarita3件の研究
- Mountain View3件の研究
- Buena Park3件の研究
- Long Beach3件の研究
公式研究テキスト（英語）
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Inglewood Clinical- Site Number : 8400074, Los Angeles
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- 他2件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- California Medical Research Associates Inc., Northridge
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
被験者募集中第2相
40歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- 他3件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Newport Native MD- Site Number : 8403003, Newport Beach
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/21更新 · NCT07793409A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Los Angeles
- Research Site, Palo Alto
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- Stanford Center for Excellence in Pulmonary Biology, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- 他1件
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- 他12件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/11更新 · NCT07555483STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
被験者募集中第3相
40歳以上 · 全性別 · 2026/07/31更新 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/06/04更新 · NCT04722835SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
被験者募集中観察研究健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
被験者募集中
22歳以上 · 全性別 · 2026/06/03更新 · NCT07119229The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
被験者募集中第2相
40歳〜79歳 · 全性別 · 2026/06/03更新 · NCT05237505Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
被験者募集中
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/16更新 · NCT06505603Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
被験者募集中
40歳〜90歳 · 全性別 · 2025/12/01更新 · NCT05572632Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
被験者募集中観察研究健康なボランティア歓迎
30歳以上 · 全性別 · 2023/10/27更新 · NCT03263130ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。